Leptin: a novel therapeutic target in Alzheimer's disease?

Beccano-Kelly, Dayne ORCID: https://orcid.org/0000-0003-3592-8354 and Harvey, Jenni 2012. Leptin: a novel therapeutic target in Alzheimer's disease? International Journal of Alzheimer’s Disease 2012 , 594137. 10.1155/2012/594137

Full text not available from this repository.

Abstract

It is well established that the hormone leptin circulates in the plasma in amounts proportional to body fat content and it regulates food intake and body weight via its actions in the hypothalamus. However, numerous studies have shown that leptin receptors are widely expressed throughout the CNS and evidence is growing that leptin plays a role in modulating a variety of neuronal processes. In particular, recent studies have highlighted a potential cognitive enhancing role for leptin as it regulates diverse aspects of hippocampal synaptic function that are thought to underlie learning and memory processes including glutamate receptor trafficking, dendritic morphology, and activity-dependent synaptic plasticity. Characterisation of the novel actions of leptin in limbic brain regions is providing valuable insights into leptin’s role in higher cognitive functions in health and disease.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Date of Acceptance:	15 October 2011
Last Modified:	10 Nov 2022 11:20
URI:	https://orca.cardiff.ac.uk/id/eprint/150128

Citation Data

Cited 30 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item